Deals & Cases
Schellenberg Wittmer advises AOP Orphan Pharmaceuticals on its license agreement with Eagle Pharmaceuticals
09.08.2021
Schellenberg Wittmer assisted AOP Orphan Pharmaceuticals on its recent license agreement with Eagle Pharmaceuticals regarding U.S. rights for Landiolol, a beta blocker.
The team of Schellenberg Wittmer consisted of Philipp Groz and Prof. Dr. Peter Georg Picht (both Intellectual Property and Life Sciences) as well as Roland Mathys and Amalie Wijesundera (both Data Protection).
Share
Further Information
View Press ReleaseContact
Schellenberg Wittmer advised on the financing of ATP's acquisition of Neschen Coating
08.10.2024
Schellenberg Wittmer advised ams-OSRAM on the sale of the Passive Optical Components Assets
07.10.2024
Schellenberg Wittmer advises Meeberg Leasing Switzerland AG in a secured EUR 63 million financing transaction
26.09.2024